Skip to main content

Optimal Cardiovascular Health Among People With Type 2 Diabetes May Offset Dementia Risk

Research Highlights:

  • Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 metrics, may decrease the risk of mild cognitive impairment and dementia for adults with Type 2 diabetes.
  • Among adults with both Type 2 diabetes and a high genetic risk for dementia, researchers found that having moderate or high cardiovascular health, compared to having low cardiovascular health, greatly lowered the risk of developing mild cognitive impairment and dementia over 13 years.
  • Note: The study featured in this news release is a research abstract. Abstracts presented at American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as full manuscripts in a peer-reviewed scientific journal.

Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 3, 2025

According to the American Heart Association’s 2025 Heart Disease and Stroke Statistics Update, Type 2 diabetes is associated with worse cognitive functioning and faster cognitive decline. This study examined the combined impact of cardiovascular health, based on the Heart Association’s Life’s Essential 8, or LE8, and a high genetic risk for dementia on the risk of developing mild cognitive impairment and dementia in adults with Type 2 diabetes.

Life’s Essential 8 is a measure of cardiovascular health that includes eight essential components for ideal heart and brain health, as identified by the American Heart Association - 4 health behaviors and 4 health factors, including:

  • Eat better.
  • Be more active.
  • Quit tobacco.
  • Get healthy sleep.
  • Manage weight.
  • Control cholesterol.
  • Manage blood sugar.
  • Manage blood pressure.

“There are multiple factors associated with Type 2 diabetes that contribute to an increased risk of cognitive decline and dementia. People with Type 2 diabetes tend to have more obesity, higher blood pressure and insulin resistance. Controlling all those factors is also good for improving cardiovascular health,” said study corresponding author Yilin Yoshida, Ph.D., M.P.H., FAHA, an assistant professor of medicine and head of a research lab which studies precision diabetes management at Tulane University School of Medicine in New Orleans. “Our study found that following steps to improve cardiovascular health can also reduce the risk for cognitive impairment among people with Type 2 diabetes.”

Researchers examined health and genetic data in the UK Biobank for more than 40,000 dementia-free adults with Type 2 diabetes. They assessed the joint effects of cardiovascular health and a genetic risk for dementia on the risk of developing mild cognitive impairment and dementia over 13 years.

An Alzheimer’s disease-based polygenic risk score was used to predict incident dementia and to capture genetic susceptibility to cognitive decline, with genetic risk categorized by high, moderate and low.

The analysis found:

  • During the 13-year follow-up period, 840 of the participants developed mild cognitive impairment and 1,013 developed dementia.
  • Overall, after adjusting for age, sex and race, participants with moderate or high cardiovascular health had a 15% lower risk of developing mild cognitive impairment and a 15% lower risk of developing dementia compared to those with low cardiovascular health.
  • Among participants with a high genetic risk score, those with moderate or high cardiovascular health had a 27% lower risk of developing mild cognitive impairment and a 23% lower risk of developing dementia compared to those with low cardiovascular health.
  • Better cardiovascular health scores were also positively and significantly associated with brain volume, signifying that people with higher Life’s Essential 8 scores were more likely to have maintained brain volume. While a loss of brain volume is a natural part of the aging process, it is also a feature of cognitive decline and dementia.
  • An analysis of U.S. adults showed similar trends.

“Genes are not destiny. Maintaining optimal cardiovascular health can protect brain health even for people with Type 2 diabetes who carry the highest genetic risk for dementia,” said study first author Xiu Wu, Ph.D., a postdoctoral fellow of medicine in the Yilin Yoshida Lab at Tulane University School of Medicine in New Orleans. “That means, if you have a family history of Alzheimer’s or cognitive impairment, you can make the modifiable lifestyle changes that may help protect yourself.”

“There has been previous research showing the benefits of following Life’s Essential 8 to reduce cognitive impairment in other populations, so it is interesting to observe these study results supporting similar findings among people with Type 2 diabetes, whom we know are also at increased risk for Alzheimer’s disease and dementia,” said Hugo Aparicio, M.D., M.P.H., FAHA, volunteer chair of the American Heart Association’s Stroke Council Brain Health Committee. “It’s another great example of what’s good for the heart is good for the brain, even when your genes may be stacked against you.” Aparicio, who was not involved in this study, is an associate professor of Neurology at Boston University Chobanian & Avedisian School of Medicine.

The researchers noted the study had some limitations. It was an observational review of data and cannot establish cause and effect. Since most people do not undergo testing for genetic risk for dementia they may not know if they are at risk for it or not, although it is not known if participants in this study had such genetic testing.

“In the past, we focused on the message: live healthy, live long. However, it’s not just living long, it’s living long and maintaining our cognitive function and capacity for longer independence and better quality of life. Our study’s findings support that you can do both,” Yoshida said. “Maintaining optimal cardiovascular health can protect brain health even for people with Type 2 diabetes who carry the highest genetic risk for dementia.”

Study details, background or design:

  • Health and genetic data were taken from the UK Biobank, a large-scale biomedical database that includes genetic and health information for over 500,000 adults living in the United Kingdom, ages 40 to 69 years when they enrolled between 2006 and 2010.
  • This analysis included cardiovascular health data for 15,613 dementia-free adults with Type 2 diabetes. An additional analysis of 20,160 dementia-free adults from the National Institutes of Health’s All of Us Research Hub was also reviewed for comparison to a representative U.S. population.
  • Cardiovascular health was assessed using the American Heart Association’s Life’s Essential 8 score. Cardiovascular health was classified as high (80-100 score), moderate (50-79 score) and low (0-49 score) based on eight metrics: smoking status, physical activity, diet, sleep, body mass index, blood pressure, blood glucose levels and cholesterol levels. The data was collected at the initial assessment visit (2006-2010) at which participants were recruited and consent given, then repeated during a repeat assessment visit (2012-13), at an initial imaging visit after 2014 and at a repeat imaging visit after 2019.
  • A group of more than 20,000 dementia-free adults from the National Institutes of Health’s All of Us Research Hub was also reviewed for a comparison representative of the general U.S. population. Researchers noted 667 adults had mild cognitive impairment and 538 adults had dementia during a 15-year follow-up period.

Co-authors, disclosures and funding sources are listed in the abstract.

Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries and American Heart Association Expert Perspective: American Heart Association Communications & Media Relations: 214-706-1173;ahacommunications@heart.org

Cathy Lewis: cathy.lewis@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.05
+11.83 (4.84%)
AAPL  268.33
-2.04 (-0.75%)
AMD  258.88
+2.75 (1.08%)
BAC  53.23
-0.22 (-0.40%)
GOOG  282.83
+1.01 (0.36%)
META  645.30
-3.05 (-0.47%)
MSFT  517.43
-0.38 (-0.07%)
NVDA  210.47
+7.98 (3.94%)
ORCL  259.05
-3.56 (-1.36%)
TSLA  468.64
+12.08 (2.65%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.